Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Inherited Metabolic Disease
Published in: Journal of Inherited Metabolic Disease 2-3/2006

01-04-2006 | SSIEM SYMPOSIUM 2005

Inborn error of amino acid synthesis: Human glutamine synthetase deficiency

Authors: Johannes Häberle, Boris Görg, Annick Toutain, Frank Rutsch, Jean-François Benoist, Antoinette Gelot, Annie-Laure Suc, Hans Georg Koch, Freimut Schliess, Dieter Häussinger

Published in: Journal of Inherited Metabolic Disease | Issue 2-3/2006

Login to get access
Metadata
Title
Inborn error of amino acid synthesis: Human glutamine synthetase deficiency
Authors
Johannes Häberle
Boris Görg
Annick Toutain
Frank Rutsch
Jean-François Benoist
Antoinette Gelot
Annie-Laure Suc
Hans Georg Koch
Freimut Schliess
Dieter Häussinger
Publication date
01-04-2006
Publisher
Kluwer Academic Publishers
Published in
Journal of Inherited Metabolic Disease / Issue 2-3/2006
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-006-0256-5

Other articles of this Issue 2-3/2006

Journal of Inherited Metabolic Disease 2-3/2006 Go to the issue

SSIEM SYMPOSIUM 2005

‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: Long-term outcome and effects of expanded newborn screening using tandem mass spectrometry

SSIEM SYMPOSIUM 2005

Hepatocyte transplantation: Studies in preclinical models

SSIEM SYMPOSIUM 2005

Trends in haematopoietic cell transplantation for inborn errors of metabolism

SSIEM SYMPOSIUM 2005

Breast feeding in IMD

SSIEM SYMPOSIUM 2005

Liver transplantation for inborn errors of liver metabolism

SSIEM SYMPOSIUM 2005

Screening for lysosomal storage disorders—A clinical perspective
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits